Drotaverine tablets 40 mg blister No. 20

Drotaverine tablets are indicated for therapeutic purposes for:

As an adjunctive treatment for:

Composition

Active ingredient: drotaverine;

1 tablet contains drotaverine hydrochloride in terms of 100% dry matter 40 mg;

Excipients: lactose monohydrate, potato starch; povidone, magnesium stearate, croscarmellose sodium.

Contraindication

Hypersensitivity to drotaverine or to other components of the drug; severe hepatic, renal or heart failure (small cardiac output syndrome).

Method of application

Drotaverine is administered orally.

Adults: the average daily dose is 120-240 mg (3-6 tablets), divided into 2-3 doses.

Children 6-12 years old: the maximum daily dose is 80 mg, divided into 2 doses.

Children over 12 years of age: the maximum daily dose is 160 mg, divided into 2-4 doses.

The duration of treatment is determined individually.

Application features

Pregnant women

The drug should be used with caution during pregnancy.

Children

The use of the drug is contraindicated in children under 6 years of age.

Drivers

If patients experience dizziness after using the drug, they should avoid potentially hazardous activities, such as driving and performing work that requires increased attention.

Overdose

Symptoms: with a significant overdose of drotaverine, cardiac rhythm and conduction disturbances have been observed, including complete bundle branch block and cardiac arrest, which can be fatal.

Treatment: in case of overdose, the patient should be under close medical supervision and receive symptomatic treatment, including inducing vomiting and/or gastric lavage.

Side effects

Interaction

When used simultaneously with levodopa, the antiparkinsonian effect of the latter may be reduced. This combination should be used with caution, as the antiparkinsonian effect of levodopa is reduced and rigidity and tremor are increased.

Storage conditions

Store out of the reach of children in the original packaging at a temperature not exceeding 25 °C.

Shelf life - 3 years.